Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for B-lymphoblastic leukemia/lymphoma with t(17;19) has been reported in the published literature.
No clinical trials have been registered for B-lymphoblastic leukemia/lymphoma with t(17;19).
3 publications have been identified in PubMed for B-lymphoblastic leukemia/lymphoma with t(17;19). Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Gene Therapy / Novel Therapeutics (33%).
Zeckanovic A (2026). [PMID: 40836779](https://pubmed.ncbi.nlm.nih.gov/40836779/). *Haematologica*. [Gene Therapy / Novel Therapeutics]
Kaya Z (2025). [PMID: 39810458](https://pubmed.ncbi.nlm.nih.gov/39810458/). *Turk Arch Pediatr*. [Diagnostic / Biomarker]
Lejman M (2025). [PMID: 40811980](https://pubmed.ncbi.nlm.nih.gov/40811980/). *Transl Oncol*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:15 PM UTC
European rare disease database
Common questions about B-lymphoblastic leukemia/lymphoma with t(17;19)